Skip to main content
$19.67 $1.05 (5.6%)

04:00 PM EST on 01/22/21

Omeros (NASDAQ:OMER)

CAPS Rating: 4 out of 5

Current Price $19.67 Mkt Cap $1.2B
Open $18.30 P/E Ratio 0.00
Prev. Close $19.67 Div. (Yield) $0.00 (0.0%)
Daily Range $18.30 - $19.84 Volume 832,309
52-Wk Range $8.50 - $25.46 Avg. Daily Vol. 995,470

Caps

How do you think NASDAQ:OMER will perform against the market?

Add Stock to CAPS Watchlist

All Players

60 Outperform
26 Underperform
 

All-Star Players

12 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:OMER Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (95.04)
Submitted April 08, 2014

Perhaps the secret PDUFA date for Omidria is keeping Omeros off run-up traders' catalyst calendars. The stock has been decidedly weak ahead of the FDA approval decision, which I project will occur in early June. Meanwhile, Omeros is attempting to… More

pchop12316 (< 20)
Submitted March 06, 2019

lacks the solid foundation for profitability

NASDAQ:OMER VS S&P 500 (SPY)

NASDAQ:OMER Summary

Recent Community Commentary

Read the most recent pitches from players about OMER.

Recs

0
Member Avatar Bigsef77 (72.81) Submitted: 7/23/2018 3:54:02 PM : Outperform Start Price: $6.40 NASDAQ:OMER Score: -24.42

Omeros Initiates Dosing in Phase 1 Clinical Trial for OMS527 Targeting Addiction

Recs

0
Member Avatar murphydevani (< 20) Submitted: 8/21/2015 9:24:49 AM : Underperform Start Price: $19.94 NASDAQ:OMER Score: +91.15

Target $18 - $13

Recs

0
Member Avatar mplaut100 (< 20) Submitted: 4/26/2015 3:35:25 PM : Outperform Start Price: $24.47 NASDAQ:OMER Score: -99.94

They have approved drugs and a good pipeline

Leaderboard

Find the members with the highest scoring picks in OMER.

Score Leader

vin100r

vin100r (< 20) Score: +289.63

The Score Leader is the player with the highest score across all their picks in OMER.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
vin100r < 20 8/15/2011 Outperform 3W $3.22 +510.87% +221.24% +289.63 0 Comment
KidJones 71.69 4/18/2013 Outperform 5Y $3.86 +409.59% +147.77% +261.81 0 Comment
B4ngZ00m < 20 3/4/2013 Outperform 5Y $5.35 +267.66% +152.29% +115.37 0 Comment
Biotechbillions < 20 7/16/2013 Outperform 5Y $5.77 +240.90% +127.55% +113.35 0 Comment
uconn777 < 20 7/1/2010 Underperform 5Y $7.33 +168.35% +277.74% +109.39 0 Comment
stover87 < 20 2/4/2013 Outperform 1Y $5.61 +250.62% +154.82% +95.80 1 Comment
murphydevani < 20 8/21/2015 Underperform 3Y $19.94 -1.35% +89.80% +91.15 1 Comment
stainsolution 72.94 2/12/2013 Outperform 5Y $5.73 +243.28% +152.26% +91.02 0 Comment
Marmadukemark 60.10 7/2/2012 Underperform 5Y $10.29 +91.16% +180.54% +89.38 0 Comment
SneakyPete21 < 20 11/29/2010 Underperform 5Y $8.34 +135.85% +223.11% +87.25 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OMER.